169 related articles for article (PubMed ID: 22189627)
1. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
Shubbar E; Vegfors J; Carlström M; Petersson S; Enerbäck C
Breast Cancer Res Treat; 2012 Jul; 134(1):71-80. PubMed ID: 22189627
[TBL] [Abstract][Full Text] [Related]
2. Psoriasin (S100A7) promotes stress-induced angiogenesis.
Vegfors J; Ekman AK; Stoll SW; Bivik Eding C; Enerbäck C
Br J Dermatol; 2016 Dec; 175(6):1263-1273. PubMed ID: 27155199
[TBL] [Abstract][Full Text] [Related]
3. A putative role for psoriasin in breast tumor progression.
Krop I; März A; Carlsson H; Li X; Bloushtain-Qimron N; Hu M; Gelman R; Sabel MS; Schnitt S; Ramaswamy S; Kleer CG; Enerbäck C; Polyak K
Cancer Res; 2005 Dec; 65(24):11326-34. PubMed ID: 16357139
[TBL] [Abstract][Full Text] [Related]
4. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
[TBL] [Abstract][Full Text] [Related]
5. The expression of Psoriasin (S100A7) and CD24 is linked and related to the differentiation of mammary epithelial cells.
Vegfors J; Petersson S; Kovács A; Polyak K; Enerbäck C
PLoS One; 2012; 7(12):e53119. PubMed ID: 23300877
[TBL] [Abstract][Full Text] [Related]
6. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
8. Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE.
Matsui T; Oda E; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2015 Jan; 14():1. PubMed ID: 25582325
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
Liang H; Zhong Y; Zhou S; Peng L
Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
[TBL] [Abstract][Full Text] [Related]
10. Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells.
Feng L; Zhu MM; Zhang MH; Wang RS; Tan XB; Song J; Ding SM; Jia XB; Hu SY
J Ethnopharmacol; 2013 Jun; 148(1):27-36. PubMed ID: 23528363
[TBL] [Abstract][Full Text] [Related]
11. Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants.
Carlsson H; Yhr M; Petersson S; Collins N; Polyak K; Enerbäck C
Cancer Biol Ther; 2005 Sep; 4(9):998-1005. PubMed ID: 16082188
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
13. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells.
Petersson S; Bylander A; Yhr M; Enerbäck C
BMC Cancer; 2007 Nov; 7():205. PubMed ID: 17986321
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
16. RNA interference‑mediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro.
Song J; Cao L; Li Y
Mol Med Rep; 2013 May; 7(5):1651-5. PubMed ID: 23467576
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
18. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.
Cui P; Yu M; Peng X; Dong L; Yang Z
J Pineal Res; 2012 Mar; 52(2):236-43. PubMed ID: 21913973
[TBL] [Abstract][Full Text] [Related]
19. [Cryptotanshinone down-regulates the expression of VEGF and inhibits angiogenesis in U2OS osteosarcoma cells].
Xu Y; Ji Q; Zhang Q; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):29-33. PubMed ID: 26728374
[TBL] [Abstract][Full Text] [Related]
20. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
